查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1667817

2025 年全球植入式心律管理设备市场报告

Implantable Cardiac Rhythm Management Device Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年植入式心律管理设备的市场规模将强劲成长。 2029 年将成长至 232.7 亿美元，年复合成长率（CAGR）为 6.8%。预测期内的成长可归因于向无线设备、远端病人监控的转变、对心臟衰竭管理的关注、在新兴市场的日益普及以及研发合作。预测期内的主要趋势包括生物可吸收技术的出现、人工智慧（AI）的整合、技术进步、远端监控和远端医疗的整合、无导线心律调节器的进步、无线充电和电源管理。

心臟病发病率的上升预计将大幅推动植入式心律管理设备市场的成长。心臟病是指影响心臟和血管的疾病。植入式心律管理装置旨在透过重新同步心室心律不整，从而帮助患有心臟衰竭或左心室功能减弱的患者。因此，心臟病发病率的不断上升将推动对这些设备的需求。例如，2024年9月，英国心血管研究慈善机构英国心臟基金会的资料显示，英国约有760万人患有心臟和循环系统疾病。其中约有400万男性和360万名女性受到该疾病的影响，占英国所有死亡人数的27%左右，每年导致超过17万人死亡。因此，心臟病盛行率的上升是推动植入式心律管理设备市场成长的关键因素。

预计未来几年老龄人口的增加将显着推动植入式心律管理设备市场的成长。老化是指人口结构中相当一部分呈现老化趋势，居民平均年龄不断上升。植入式心律管理装置经常被该族群用于解决和管理各种心臟相关问题。例如，美国非营利组织人口研究所2024年1月预测，到2050年，美国数将增加47％，从2022年的5,800万人增加至8,200万人。此外，这一年龄层占总人口的比例预计将在同一时期从17％增加到23％。因此，老化人口的不断成长是推动植入式心律管理设备市场成长的关键因素。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球植入式心律管理设备市场的 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球植入式心律管理设备市场：成长率分析
  • 全球植入式心律管理设备市场表现：规模与成长，2019 年至 2024 年
  • 全球植入式心律管理设备市场预测：2024-2029 年、2034 年规模与成长
  • 植入式心律管理设备的全球总目标市场 (TAM)

第六章 市场细分

  • 全球植入式心律管理设备市场（按设备、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 心臟再同步化治疗
  • 心臟去颤器
  • 心律调节器
  • 全球植入式心律管理设备市场（按应用、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 心搏过缓
  • 心搏过速
  • 其他的
  • 全球植入式心律管理设备市场（依最终用途、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 心臟专科中心
  • 其他的
  • 全球植入式心律管理设备市场：心臟再同步治疗 (CRT) 细分市场按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • CRT-P（心律心律调节器）
  • CRT-D（心臟去颤器）
  • 全球植入式心律管理设备市场：心臟去颤器按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 植入式心臟整流去颤器(ICD)
  • 植入式心臟整流去颤器(S-ICD)
  • 全球植入式心律管理设备市场：心律调节器细分类型、效能及预测，2019-2024 年、2024-2029 年、2034 年
  • 单腔心律调节器
  • 双腔心律调节器
  • 双心室心律调节器

第七章 区域和国家分析

  • 全球植入式心律管理设备市场各地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式心律管理设备市场（依国家/地区划分）、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 植入式心律管理设备市场：竞争格局
  • 植入式心律管理设备市场：公司简介
    • Schiller AG Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Zoll Medical Corporation
  • Biotronik Ltd.
  • MicroPort Scientific Corporation
  • Abiomed Inc
  • Nihon Kohden Corporation
  • Japan Lifeline Co. Ltd.
  • Lepu Medical Technology Co. Ltd.
  • LivaNova PLC
  • Shenzhen Mindray Biomedical Electronics Co. Ltd
  • Progetti Srl
  • Edwards Lifesciences Corporation
  • Cardiac Science Corporation
  • Bardy Diagnostics Inc.
  • Beijing Demax Medical Technology Co. Ltd
  • iRhythm Technologies Inc.

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年植入式心律管理设备市场：提供新机会的国家
  • 2029 年植入式心律管理设备市场：细分市场将带来新机会
  • 植入式心律管理设备市场 2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r24222

Implantable cardiac rhythm management devices are small battery-operated devices that are surgically inserted inside the body and connected to the heart, playing a crucial role in maintaining and managing heart rhythm.

The primary devices in the category of implantable cardiac rhythm management devices include cardiac resynchronization therapy, defibrillators, and pacemakers. Cardiac resynchronization therapy (CRT) is a specialized treatment designed for severe cardiac rhythm issues. These devices find applications in various conditions such as bradycardia, tachycardia, and others, and are utilized in hospitals, specialty cardiac centers, and other medical settings.

The implantable cardiac rhythm management device market research report is one of a series of new reports from The Business Research Company that provides implantable cardiac rhythm management device market statistics, including implantable cardiac rhythm management device industry global market size, regional shares, competitors with implantable cardiac rhythm management device market share, detailed implantable cardiac rhythm management device market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable cardiac rhythm management device industry. This implantable cardiac rhythm management device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable cardiac rhythm management device market size has grown steadily in recent years. It will grow from$17.06 billion in 2024 to $17.87 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to the aging population, increasing incidence of cardiac arrhythmias, awareness and education initiatives, healthcare infrastructure development, and rising healthcare expenditure

The implantable cardiac rhythm management device market size is expected to see strong growth in the next few years. It will grow to $23.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to a shift towards leadless devices, remote patient monitoring, a focus on heart failure management, increased adoption in emerging markets, and collaborations for research and development. Major trends in the forecast period include the emergence of bioresorbable technologies, integration of artificial intelligence (AI), advancements in technology, remote monitoring and telemedicine integration, advancements in leadless pacemakers, wireless charging, and power management.

The rising incidence of cardiac disorders is anticipated to significantly enhance the growth of the implantable cardiac rhythm management devices market. Cardiac disorders refer to conditions that impact the heart or blood vessels. Implantable cardiac rhythm management devices are designed to assist patients with heart failure and diminished left ventricular function by improving systolic function through the resynchronization of heart contractions and restoring normal rhythm during life-threatening rapid ventricular arrhythmias. As a result, the growing prevalence of cardiac disorders will drive demand for these devices. For instance, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, revealed that approximately 7.6 million individuals in the UK are affected by heart and circulatory diseases. This includes about 4 million men and 3.6 million women living with these conditions, which account for roughly 27% of all deaths in the UK, translating to over 170,000 fatalities each year, or about 480 deaths per day-equivalent to one death every three minutes. Therefore, the increasing prevalence of cardiac disorders is a key factor propelling the growth of the implantable cardiac rhythm management devices market.

The growing aging population is anticipated to significantly drive the growth of the implantable cardiac rhythm management devices market in the coming years. An aging population refers to a demographic trend where a significant portion of a country's citizens are becoming older, leading to a higher average age among its residents. Implantable cardiac rhythm management devices are frequently utilized within this demographic to address and manage various heart-related issues. For example, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Additionally, this age group's proportion of the total population is expected to increase from 17% to 23% over the same period. Consequently, the expanding aging population is a key factor propelling the growth of the implantable cardiac rhythm management devices market.

Technological advancement stands out as a prominent trend in the implantable cardiac rhythm management devices market, with major companies focusing on developing innovative technologies to maintain their market position. Rhythm Management Group PLLC, a US-based company, introduced RhythmSynergy in April 2022, a technology platform that utilizes machine learning to deliver timely clinical insights for patients monitored remotely with implantable cardiac devices and wearable devices. This platform streamlines the review processes by combining clinical knowledge and machine learning technologies, making it simpler to review, share, and analyze patient data.

Major companies in the implantable cardiac rhythm management devices market prioritize the launch of innovative products such as implantable cardiac defibrillators. In October 2023, MicroPort CRM, a France-based manufacturer, launched the ULYS Implantable Cardioverter Defibrillator (ICDs) and INVICTA defibrillation implantable devices. The ULYS ICD integrates cutting-edge technology with minimal energy consumption, featuring the AutoMRI function and PARAD arrhythmia discrimination algorithm. The INVICTA defibrillation lead consistently senses electrical signals from the right ventricle, providing pacing therapy if the heart rate is too low.

In August 2022, Medtronic, a US-based medical technology company, completed the acquisition of Affera Inc. for an undisclosed amount. This acquisition grants Medtronic access to the Affera Prism-1TM cardiac mapping and navigation platform, compatible with both Medtronic therapeutic catheters and various competing technologies. Affera Inc., a US-based medical technology company, specializes in manufacturing cardiac mapping and navigation systems for treating patients with cardiac arrhythmias.

Major companies operating in the implantable cardiac rhythm management device market include Schiller AG, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation, Biotronik Ltd., MicroPort Scientific Corporation, Abiomed Inc, Nihon Kohden Corporation, Japan Lifeline Co. Ltd., Lepu Medical Technology Co. Ltd., LivaNova PLC, Shenzhen Mindray Biomedical Electronics Co. Ltd, Progetti Srl, Edwards Lifesciences Corporation, Cardiac Science Corporation, Bardy Diagnostics Inc., Beijing Demax Medical Technology Co. Ltd, iRhythm Technologies Inc., Impulse Dynamics plc., VytronUS Inc.

North America was the largest region in the implantable cardiac rhythm management device market in 2024. The regions covered in the implantable cardiac rhythm management device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the implantable cardiac rhythm management device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable cardiac rhythm management devices market consists of sales of the leadless pacemaker, insertable cardiac monitor, cardiac leads, and subcutaneous implantable defibrillator (S-ICD). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardiac Rhythm Management Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardiac rhythm management device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardiac rhythm management device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable cardiac rhythm management device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device: Cardiac Resynchronization Therapy; Defibrillators; Pacemakers
  • 2) By Application: Bradycardia; Tachycardia; Other Applications
  • 3) By End-Use: Hospitals; Specialty Cardiac Centers; Other End-Uses
  • Subsegments:
  • 1) By Cardiac Resynchronization Therapy (CRT): CRT-P (Pacemaker); CRT-D (Defibrillator)
  • 2) By Defibrillators: Implantable Cardioverter Defibrillators (ICDs); Subcutaneous Implantable Defibrillators (S-ICDs)
  • 3) By Pacemakers: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers
  • Companies Mentioned: Schiller AG; Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Koninklijke Philips N.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardiac Rhythm Management Device Market Characteristics

3. Implantable Cardiac Rhythm Management Device Market Trends And Strategies

4. Implantable Cardiac Rhythm Management Device Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Implantable Cardiac Rhythm Management Device Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Cardiac Rhythm Management Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Cardiac Rhythm Management Device Market Growth Rate Analysis
  • 5.4. Global Implantable Cardiac Rhythm Management Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Cardiac Rhythm Management Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Cardiac Rhythm Management Device Total Addressable Market (TAM)

6. Implantable Cardiac Rhythm Management Device Market Segmentation

  • 6.1. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Resynchronization Therapy
  • Defibrillators
  • Pacemakers
  • 6.2. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bradycardia
  • Tachycardia
  • Other Applications
  • 6.3. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Cardiac Centers
  • Other End-Uses
  • 6.4. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CRT-P (Pacemaker)
  • CRT-D (Defibrillator)
  • 6.5. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Cardioverter Defibrillators (ICDs)
  • Subcutaneous Implantable Defibrillators (S-ICDs)
  • 6.6. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers

7. Implantable Cardiac Rhythm Management Device Market Regional And Country Analysis

  • 7.1. Global Implantable Cardiac Rhythm Management Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Cardiac Rhythm Management Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardiac Rhythm Management Device Market

  • 8.1. Asia-Pacific Implantable Cardiac Rhythm Management Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardiac Rhythm Management Device Market

  • 9.1. China Implantable Cardiac Rhythm Management Device Market Overview
  • 9.2. China Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardiac Rhythm Management Device Market

  • 10.1. India Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardiac Rhythm Management Device Market

  • 11.1. Japan Implantable Cardiac Rhythm Management Device Market Overview
  • 11.2. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardiac Rhythm Management Device Market

  • 12.1. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardiac Rhythm Management Device Market

  • 13.1. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardiac Rhythm Management Device Market

  • 14.1. South Korea Implantable Cardiac Rhythm Management Device Market Overview
  • 14.2. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardiac Rhythm Management Device Market

  • 15.1. Western Europe Implantable Cardiac Rhythm Management Device Market Overview
  • 15.2. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardiac Rhythm Management Device Market

  • 16.1. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardiac Rhythm Management Device Market

  • 17.1. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardiac Rhythm Management Device Market

  • 18.1. France Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardiac Rhythm Management Device Market

  • 19.1. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardiac Rhythm Management Device Market

  • 20.1. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardiac Rhythm Management Device Market

  • 21.1. Eastern Europe Implantable Cardiac Rhythm Management Device Market Overview
  • 21.2. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardiac Rhythm Management Device Market

  • 22.1. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardiac Rhythm Management Device Market

  • 23.1. North America Implantable Cardiac Rhythm Management Device Market Overview
  • 23.2. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardiac Rhythm Management Device Market

  • 24.1. USA Implantable Cardiac Rhythm Management Device Market Overview
  • 24.2. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardiac Rhythm Management Device Market

  • 25.1. Canada Implantable Cardiac Rhythm Management Device Market Overview
  • 25.2. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardiac Rhythm Management Device Market

  • 26.1. South America Implantable Cardiac Rhythm Management Device Market Overview
  • 26.2. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardiac Rhythm Management Device Market

  • 27.1. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardiac Rhythm Management Device Market

  • 28.1. Middle East Implantable Cardiac Rhythm Management Device Market Overview
  • 28.2. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardiac Rhythm Management Device Market

  • 29.1. Africa Implantable Cardiac Rhythm Management Device Market Overview
  • 29.2. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardiac Rhythm Management Device Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Cardiac Rhythm Management Device Market Competitive Landscape
  • 30.2. Implantable Cardiac Rhythm Management Device Market Company Profiles
    • 30.2.1. Schiller AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardiac Rhythm Management Device Market Other Major And Innovative Companies

  • 31.1. Zoll Medical Corporation
  • 31.2. Biotronik Ltd.
  • 31.3. MicroPort Scientific Corporation
  • 31.4. Abiomed Inc
  • 31.5. Nihon Kohden Corporation
  • 31.6. Japan Lifeline Co. Ltd.
  • 31.7. Lepu Medical Technology Co. Ltd.
  • 31.8. LivaNova PLC
  • 31.9. Shenzhen Mindray Biomedical Electronics Co. Ltd
  • 31.10. Progetti Srl
  • 31.11. Edwards Lifesciences Corporation
  • 31.12. Cardiac Science Corporation
  • 31.13. Bardy Diagnostics Inc.
  • 31.14. Beijing Demax Medical Technology Co. Ltd
  • 31.15. iRhythm Technologies Inc.

32. Global Implantable Cardiac Rhythm Management Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardiac Rhythm Management Device Market

34. Recent Developments In The Implantable Cardiac Rhythm Management Device Market

35. Implantable Cardiac Rhythm Management Device Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Cardiac Rhythm Management Device Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Cardiac Rhythm Management Device Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Cardiac Rhythm Management Device Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer